CeaseCancer/Bio-XL

Website
AI,BioTech,HealthTech

Company Bio

CeaseCancer is developing a first-in-class disease-modifying therapy for pancreatic cancer by targeting key disease mechanisms. Designed for use alone or with standard treatments, it aims to improve efficacy, survival, and quality of life for patients with this highly aggressive cancer